These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 31765575)

  • 21. Effect of a Preparation of Four Probiotics on Symptoms of Patients with Irritable Bowel Syndrome: Association with Intestinal Bacterial Overgrowth.
    Leventogiannis K; Gkolfakis P; Spithakis G; Tsatali A; Pistiki A; Sioulas A; Giamarellos-Bourboulis EJ; Triantafyllou K
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):627-634. PubMed ID: 29508268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study.
    Scarpellini E; Giorgio V; Gabrielli M; Lauritano EC; Pantanella A; Fundarò C; Gasbarrini A
    J Pediatr; 2009 Sep; 155(3):416-20. PubMed ID: 19535093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Small intestinal bacterial overgrowth in patients with functional gastrointestinal diseases].
    Madrid AM; Defilippi C C; Defilippi G C; Slimming A J; Quera P R
    Rev Med Chil; 2007 Oct; 135(10):1245-52. PubMed ID: 18180830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrogen sulphide in exhaled breath: a potential biomarker for small intestinal bacterial overgrowth in IBS.
    Banik GD; De A; Som S; Jana S; Daschakraborty SB; Chaudhuri S; Pradhan M
    J Breath Res; 2016 May; 10(2):026010. PubMed ID: 27163246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis.
    Gandhi A; Shah A; Jones MP; Koloski N; Talley NJ; Morrison M; Holtmann G
    Gut Microbes; 2021; 13(1):1933313. PubMed ID: 34190027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of small intestinal bacterial overgrowth on symptoms and quality of life in irritable bowel syndrome.
    Chuah KH; Hian WX; Lim SZ; Beh KH; Mahadeva S
    J Dig Dis; 2023 Mar; 24(3):194-202. PubMed ID: 37200005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microscopic colitis and small intestinal bacterial overgrowth--diagnosis behind the irritable bowel syndrome?
    Stoicescu A; Andrei M; Becheanu G; Stoicescu M; Nicolaie T; Diculescu M
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):766-72. PubMed ID: 23272525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress.
    Grover M; Kanazawa M; Palsson OS; Chitkara DK; Gangarosa LM; Drossman DA; Whitehead WE
    Neurogastroenterol Motil; 2008 Sep; 20(9):998-1008. PubMed ID: 18482250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.
    Pyleris E; Giamarellos-Bourboulis EJ; Tzivras D; Koussoulas V; Barbatzas C; Pimentel M
    Dig Dis Sci; 2012 May; 57(5):1321-9. PubMed ID: 22262197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial.
    Ghoshal UC; Srivastava D; Misra A; Ghoshal U
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):281-9. PubMed ID: 26731696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
    Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
    Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?
    Reddymasu SC; Sostarich S; McCallum RW
    BMC Gastroenterol; 2010 Feb; 10():23. PubMed ID: 20175924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania.
    Moraru IG; Moraru AG; Andrei M; Iordache T; Drug V; Diculescu M; Portincasa P; Dumitrascu DL
    Rom J Intern Med; 2014; 52(3):143-50. PubMed ID: 25509557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Shah A; Talley NJ; Jones M; Kendall BJ; Koloski N; Walker MM; Morrison M; Holtmann GJ
    Am J Gastroenterol; 2020 Feb; 115(2):190-201. PubMed ID: 31913194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth.
    Weinstock LB; Walters AS
    Sleep Med; 2011 Jun; 12(6):610-3. PubMed ID: 21570907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity Is Inversely Related to Hydrogen-Producing Small Intestinal Bacterial Overgrowth in Non-Constipation Irritable Bowel Syndrome.
    Jung SE; Joo NS; Han KS; Kim KN
    J Korean Med Sci; 2017 Jun; 32(6):948-953. PubMed ID: 28480652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study.
    Bustos Fernández LM; Man F; Lasa JS
    Dig Dis; 2023; 41(5):798-809. PubMed ID: 36630947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective.
    Spiegel BM
    Clin Gastroenterol Hepatol; 2011 Jun; 9(6):461-9; quiz e59. PubMed ID: 21397724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial.
    Majewski M; McCallum RW
    Adv Med Sci; 2007; 52():139-42. PubMed ID: 18217406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.